Martin Duplessis
27Patents
4h-index
69Co-inventors
62Inventor score
Filing activity: Dec 3, 2007 → May 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8349839B2 | Inhibitors of HIV replication | Chemistry; Metallurgy | 42 | Active |
| US9085583B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US9371331B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11459335B2 | N/O-linked Degrons and Degronimers for protein degradation | Physics | 4 | Active |
| US10526287B2 | LSD1 inhibitors and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9969716B2 | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10016405B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10239861B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10882848B2 | 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds | Chemistry; Metallurgy | 1 | Active |
| US12048747B2 | Substituted piperidine Degronimers for Target Protein degradation | Emerging Cross-Sectional Technologies | 1 | Active |
| US11673902B2 | Isoindolinone and indazole compounds for the degradation of EGFR | Chemistry; Metallurgy | 1 | Active |
| US11117890B2 | Substituted isoindole allosteric EGFR inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12209091B2 | Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers | Human Necessities | 1 | Active |
| US10308614B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9980952B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11708354B2 | 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds | Chemistry; Metallurgy | 1 | Active |
| US12371442B2 | Isoindolinone and indazole compounds for the degradation of EGFR | Chemistry; Metallurgy | 0 | Active |
| US9708332B2 | Respiratory syncytial virus inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10358437B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9399645B2 | Inhibitors of HIV replication | Chemistry; Metallurgy | 0 | Active |
| US10316023B2 | Therapeutic compounds and uses thereof | General | 0 | Revoked |
| US12180225B2 | N/O-linked degrons and degronimers for protein degradation | Physics | 0 | Active |
| US9334249B2 | Inhibitors of cytomegalovirus | Chemistry; Metallurgy | 0 | Active |
| US8039638B2 | Inhibitors of HIV replication | Chemistry; Metallurgy | 0 | Active |
| US10202378B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.